Ameriprise’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-244,528
| Closed | -$357K | – | 3930 |
|
|
2025
Q1 | $357K | Buy |
244,528
+42,585
| +21% | +$62.2K | ﹤0.01% | 3593 |
|
|
2024
Q4 | $430K | Buy |
201,943
+24,830
| +14% | +$52.9K | ﹤0.01% | 3555 |
|
|
2024
Q3 | $496K | Sell |
177,113
-160,932
| -48% | -$451K | ﹤0.01% | 3465 |
|
|
2024
Q2 | $788K | Buy |
338,045
+149,005
| +79% | +$347K | ﹤0.01% | 3253 |
|
|
2024
Q1 | $845K | Sell |
189,040
-1,255
| -0.7% | -$5.61K | ﹤0.01% | 3234 |
|
|
2023
Q4 | $611K | Buy |
190,295
+55,704
| +41% | +$179K | ﹤0.01% | 3369 |
|
|
2023
Q3 | $427K | Buy |
134,591
+23,415
| +21% | +$74.2K | ﹤0.01% | 3470 |
|
|
2023
Q2 | $553K | Sell |
111,176
-697,048
| -86% | -$3.46M | ﹤0.01% | 3396 |
|
|
2023
Q1 | $4M | Buy |
808,224
+167,036
| +26% | +$826K | ﹤0.01% | 2465 |
|
|
2022
Q4 | $4.03M | Sell |
641,188
-129,695
| -17% | -$816K | ﹤0.01% | 2445 |
|
|
2022
Q3 | $8.31M | Sell |
770,883
-276,682
| -26% | -$2.98M | ﹤0.01% | 1830 |
|
|
2022
Q2 | $11.9M | Buy |
1,047,565
+39,029
| +4% | +$445K | ﹤0.01% | 1590 |
|
|
2022
Q1 | $9.19M | Buy |
1,008,536
+293,874
| +41% | +$2.68M | ﹤0.01% | 1975 |
|
|
2021
Q4 | $10.7M | Buy |
714,662
+332,832
| +87% | +$4.97M | ﹤0.01% | 1939 |
|
|
2021
Q3 | $9.81M | Buy |
381,830
+353,249
| +1,236% | +$9.08M | ﹤0.01% | 1873 |
|
|
2021
Q2 | $745K | Buy |
28,581
+4,234
| +17% | +$110K | ﹤0.01% | 3320 |
|
|
2021
Q1 | $859K | Sell |
24,347
-4,927
| -17% | -$174K | ﹤0.01% | 3202 |
|
|
2020
Q4 | $739K | Sell |
29,274
-1,469
| -5% | -$37.1K | ﹤0.01% | 3208 |
|
|
2020
Q3 | $1.16M | Sell |
30,743
-3,753
| -11% | -$141K | ﹤0.01% | 2904 |
|
|
2020
Q2 | $1.48M | Buy |
+34,496
| New | +$1.48M | ﹤0.01% | 2747 |
|